Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C
1. Routine use of prophylactic twice-daily enoxaparin demonstrated adequate safety in children with acute COVID-19 and multisystem inflammatory syndrome in children ...
![siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/04/clot-CCWiki-350x250.jpg)


